• Info
  • Insider Ownership

Insider Trading & Ownership of Jan Skvarka

Location
Mississauga, Ontario, Canada
Summary
The estimated net worth of Jan Skvarka is at least $267,228 dollars as of 18 Jun 2025. Jan Skvarka is the Director of Zentalis Pharmaceuticals, Inc. and owns shares of Zentalis Pharmaceuticals, Inc. (ZNTL) stock worth about $267.2K.
Signature
/s/ Andrea Paul, attorney-in-fact for Jan Skvarka
All Insider Reports
All Insider Reports

Notify me when Jan Skvarka files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Jan Skvarka

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
ZNTL Zentalis Pharmaceuticals, Inc. Director $267,228 +$103,446 +63% 17 Jun 2025
GLUE Monte Rosa Therapeutics, Inc. Director 13 Jun 2025
TRIL Trillium Therapeutics Inc. President and CEO, Director 17 Nov 2021

Insider Transactions Reported by Jan Skvarka:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.